Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposal of own shares

INFORMATION REGLEMENTEE


[13/01/2020 | 20:05]
https://mb.cision.com/Public/18595/3007977/b8aae7050fa7d9c4_800x800ar.jpg

** Disposal of own shares
------------------------------------------------------------

Brussels (Belgium), 13 January 2020 =E2=80=93 20:05 (CET) =E2=80=93 regulat=
ed information

In application of article 8:6 of the Royal Decree executing the new Belgian=
Code of Companies and Associations, UCB SA/NV announces that following exe=
rcises of stock options by its employees, it has disposed of UCB shares OTC=
in view of deliveries of shares to the relevant employees, within the fram=
ework of the Long Term Incentive Program of the UCB Group, as follows:

https://mb.cision.com/Public/18595/3007977/91039f8b421bbfa9_800x800ar.jpg
=C2=A0=C2=A0
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://www.ucb.com/stories-media/Press-Releases) .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i=
n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news

Image
Capture 1 Disposal of Own Shares Jan 13 2020 (https://mb.cision.com/Public/=
18595/3007977/91039f8b421bbfa9_org.jpg) GenericFile
20100113- Disposal of own shares (https://mb.cision.com/Public/18595/300797=
7/8d400e2be79e0034.pdf) GenericFile
20200113 - Ali=C3=A9nation d actions propres (https://mb.cision.com/Public/=
18595/3007977/88b8986b688b3dc1.pdf) GenericFile
20100113 - Vervreemding van eigen aandelen (https://mb.cision.com/Public/18=
595/3007977/a0ee45175a932233.pdf)=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x33323x1x6868579x24000=
x6&Email=3Dregnews%40symexglobal.com.=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=